21 CFR 1301.12 - Separate registrations for separate locations

Cite as21 CFR 1301.12
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
39 practice notes
  • Registration revocations, restrictions, denials, reinstatements: Chein, Edmund, MD,
    • United States
    • Federal Register February 12, 2007
    • February 12, 2007
    ...registrant maintain a registration at each place of business from where a registrant distributes controlled substances. 21 U.S.C. 822(e); 21 CFR 1301.12. Under DEA precedents, a registrant is responsible for violations of the CSA committed by his employees and his practice's failure to comp......
  • Annicol Marrocco, M.D.; Decision and Order
    • United States
    • Federal Register May 19, 2015
    • May 19, 2015
    ...another state is a violation of 21 U.S.C. 822(e) . . . which requires separate registrations for separate locations.'' Id. (also citing 21 CFR 1301.12(a) & (b)(3)). The Government also alleged that Respondent knowingly and willfully violated these provisions, alleging that ``DEA personn......
  • Jeffery J. Becker, D.D.S., and Jeffery J. Becker, D.D.S., Affordable Care Decision and Order
    • United States
    • Federal Register December 05, 2012
    • December 5, 2012
    ...professional practice where the applicant manufactures, distributes, or dispenses controlled substances or list I chemicals.'' See also 21 CFR 1301.12(a). While, by regulation, DEA has exempted several categories of locations from the registration requirement, with respect to practitioners,......
  • Joe W. Morgan, D.O.; Decision and Order
    • United States
    • Federal Register October 08, 2013
    • October 8, 2013
    ...place of business or professional practice where the applicant . . . dispenses controlled substances.'' Id. section 822(e). See also 21 CFR 1301.12(a) (``A separate registration is required for each principal place of business or professional practice at one general physical location where ......
  • Request a trial to view additional results
6 cases
  • Wedgewood Village Pharmacy, Inc. v. Ashcroft, Civil Action No. 03-5242(JBS).
    • United States
    • United States District Courts. 3th Circuit. United States District Courts. 3th Circuit. District of New Jersey
    • December 15, 2003
    ...manufactures, distributes, or dispenses controlled substances or list I chemicals." 21 U.S.C. § 822(e). The companion regulation, 21 C.F.R. § 1301.12(a), also provides that "[a] separate registration is required for each principal place of business or professional practice at one general lo......
  • Morall v. Drug Enforcement Admin., No. 04-1367.
    • United States
    • United States Courts of Appeals. United States Court of Appeals (District of Columbia)
    • June 24, 2005
    ...§ 827(a)(1) (2000). They are also required to hold a DEA registration at any location where they dispense controlled substances, see 21 C.F.R. § 1301.12 (2004), and to store controlled substances "in a securely locked, substantially constructed cabinet," id. § 1301.75. Finally, physicians w......
  • United States v. Butterbaugh, C14-515 TSZ
    • United States
    • United States District Courts. 9th Circuit. United States District Court (Western District of Washington)
    • August 5, 2015
    ...see Minute Order (docket no. 31), for the following reasons. First, the Government's discussion concerning the different versions of 21 C.F.R. § 1301.12(b)(3) addressed an issue raised by Butterbaugh in his response to the motion for summary judgment, which is an appropriate use of a reply.......
  • Becker v. Drug Enforcement Admin., No. 12-4559
    • United States
    • United States Courts of Appeals. United States Court of Appeals (6th Circuit)
    • October 3, 2013
    ...and dispensed without obtaining a Drug Enforcement Administration Certificate of Registration, in violation of 21 U.S.C. § 822(e) and 21 C.F.R. § 1301.12; (2) Becker's continued administering of controlled substances at the Avon location after having received notice this was in violation of......
  • Request a trial to view additional results
1 firm's commentaries
  • In Proposed Rulemaking, DEA Looks to Expand Mobile Narcotic Treatment Options
    • United States
    • JD Supra United States
    • February 28, 2020
    ...health and patient safety benefits. The proposed rule is largely based upon this authority. As currently structured under DEA statute, 21 CFR 1301.12, each “principal place of business or professional practice” must be registered as part of the dispensation of controlled substances, schedul......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT